Pneumococcal Carriage Duration

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age28-48
SponsorUniversity of Central Florida

About this trial

Streptococcus pneumoniae (SPN) remains a leading cause of respiratory disease in young children despite widespread vaccination. Understanding the duration of pneumococcal carriage, patterns of co-colonization, and the influence of viral infections and the respiratory microbiome is essential to evaluate next-generation pneumococcal vaccines and inform public health strategies. Current data on Streptococcus pneumoniae carriage dynamics are limited in U.S. pediatric populations. This study aims to generate updated estimates of Streptococcus pneumoniae colonization and explore microbial interactions using high-resolution longitudinal sampling and genomic methods.

Eligibility criteria

Qualifiers

Are older than 28 days and under 4 years of age at the time of enrollment.

Provides written informed consent.

Is able to read and speak English or Spanish.

Agrees to comply with all study procedures, including completion of questionnaires and biweekly oropharyngeal (OP) swab collections from the child for a period of 12 months.

Disqualifiers

cystic fibrosis

cerebral palsy

neuromuscular disorders

congenital heart disease

Trial design

Treatments tested in this trial

  • Oropharyngeal (OP) swab

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Central Florida

Lead sponsor

Merck Sharp & Dohme LLC

Collaborator